Kenya Shitara

This inventor holds 56 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 2 EPO patents, primarily in Recombinant Antibodies (CPC class C07K). Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kirin Co., Limited, Kyowa Kirin Co., Ltd.. Active years: 1990-2020.

USPTO Granted Patents = 56 (Patent Applications = 5)

% Patents Active = 55.4

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 16

Forward Citations = 894(Granted Patents)

Forward Citations (Not Self Cited) = 844(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Diego, CA (US) (1998 - 2005)
Chiyoda-ku, JP (2012)
Tokyo, JP (1992 - 2014)
Fujisawa, JP (2003 - 2017)
Machida, JP (1990 - 2020)

Company Filing History:

30 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

25 out of 272

Kyowa Hakko Kirin Co., Limited

patents

1 out of 46

Kyowa Kirin Co., Ltd.

patents

4. 1 out of 69

Kyowa Medex Co., Ltd.

patents

5. 1 out of 263

National Cancer Center

where one patent can have more than one assignee

Years Active: 1990-2020

Loading Chart...

Areas of Expertise:

Recombinant Antibody

CDR-Grafted Antibody

Monoclonal Antibody

Therapeutic Composition

Chemokine Receptor

Epidermal Growth Factor

Fibroblast Growth Factor

Insulin-Like Growth Factor

Th2-Mediated Disease

Cancer Treatment

Apoptosis Inducer

Diagnostic Methods

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10590203 - Human CDR-grafted antibody and antibody fragment thereof (2020-03-17),

2. 10131711 - Human CDR-grafted antibody and antibody fragment thereof (2018-11-20),

3. 9675625 - Medicament comprising recombinant antibody against chemokine receptor CCR4 (2017-06-13),

4. 9475886 - Recombinant antibody composition (2016-10-25),

5. 9051371 - Human CDR-grafted antibody and antibody fragment thereof (2015-06-09),

6. 8900584 - Human CDR-grafted antibody and antibody fragment thereof (2014-12-02),

7. 8883981 - Recombinant antibody composition (2014-11-11),

8. 8632996 - Method for producing recombinant antibody and antibody fragment thereof (2014-01-21),

9. 8492526 - Effector function enhanced recombinant antibody composition (2013-07-23),

10. 8491902 - Medicament comprising recombinant antibody against chemokine receptor CCR4 (2013-07-23),

11. 8481039 - Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor (2013-07-09),

12. 8313913 - Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa (2012-11-20),

13. 8197814 - Method for treating the Th2-mediated disease (2012-06-12),

14. 8173781 - Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor (2012-05-08),

15. 8163282 - Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor (2012-04-24),

Title: Kenya Shitara: A Trailblazing Woman in Innovation

Introduction:

Kenya Shitara, a visionary inventor based in Machida, JP, is renowned for her passion for innovation and unwavering commitment to excellence. With a stellar track record of 56 patents under her name, Shitara continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents:

Among Kenya Shitara's latest patents is the groundbreaking "Human CDR-Grafted Antibody and Antibody Fragment Thereof." This patent encompasses antibodies that specifically target the extracellular region of human CCR4, with applications in therapeutics, diagnostics, and more. Shitara's innovative approach demonstrates her profound impact on the field of biotechnology.

Career Highlights:

Having worked with esteemed companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited, Kenya Shitara has honed her skills and expertise in the realm of pharmaceuticals and biotechnology. Her contributions have significantly advanced the development of novel treatments and diagnostic tools in the medical sector.

Collaborations:

Throughout her career, Kenya Shitara has collaborated with notable professionals in the industry, including Kazuyasu Nakamura and Nobuo Hanai. These collaborative efforts have led to the creation of cutting-edge solutions that address critical healthcare challenges and improve patient outcomes.

Conclusion:

In conclusion, Kenya Shitara's remarkable journey as a pioneering female inventor exemplifies the power of passion, dedication, and innovation in driving meaningful change. Her relentless pursuit of excellence serves as a beacon of inspiration for aspiring inventors worldwide, shaping the landscape of technology and healthcare for years to come.